Abstract
Background: The topographical group of head and neck cancers (ICD-10: C00 – C14) describes a heterogeneous group of malignant tumors whose incidence, mortality, and survival vary widely by entity.

Material and methods: The basis for the calculations was obtained from the national databases and outputs of the National Cancer Registry and from the Statistical Office of the Slovak Republic, from the Account of Policy-holders from health insurance companies and from the global database outputs of the IARC WHO. A log-linear model of joinpoint regression analysis was used to analyse the time trend.
Results: The standardised incidence and mortality rates of head and neck malignant tumors in men in Slovakia have a significantly decreasing trend since 1990. In contrast, statically significant disfavourable increasing trend has been recorded in the long term for women. Since 2004 has been measured a sharp increase for women in the incidence rate. More than 75 % of newly diagnosed cases in locally advanced and metastatic clinical stages also contribute to the disfavourable survival trend.
Conclusions: Up-to-date and validated epidemiological outcomes for malignant tumours are essential for planning prevention and intervention programs in oncology (Tab. 1, Fig. 3, Ref. 21). Text in PDF www.lekarskyobzor.sk.

KEY WORDS: head and neck tumors, incidence, mortality, prevalence.

Lek Obz 2023, 72 (4): 158-163



CITE
MARKOVÁ S., SUCHANSKÝ M., ONDRUŠ D. et al.: Epidemiology of head and neck tumors in Slovakia. Lek Obz 2023, 72 (4): 158-163


Silvia MARKOVÁ 1,2, Martin SUCHANSKÝ 3, Dalibor ONDRUŠ 4, Martina ONDRUŠOVÁ 1,3

1 Katedra preventívnej a klinickej medicíny, Fakulta verejného zdravotníctva, Slovenská zdravotnícka univerzita, Bratislava, vedúca prof. MUDr. E. Horváthová, PhD., MPH
2 Universitätszahnklinik, Medizinische Universität Wien, Wien, Austria, der Vorstand Univ. Prof. DDr. E. Jonke
3 Oddelenie epidemiológie a štatistiky, Pharm-In, spol. s r.o., Bratislava, riaditeľka RNDr. M. Bucek Pšenková, MPH, MSc (HTA)
4 I. onkologická klinika LF UK a OÚSA, Bratislava, prednosta prof. MUDr. D. Ondruš, DrSc.